CAS: 1334546-77-8
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide REF: IN-DA01EGPWCAS: 1334546-77-8 | 98% | Prezzo su richiesta | Lun 13 Gen 25 |
 | Icenticaftor REF: TM-T9499CAS: 1334546-77-8 | 98.39% | 155,00 €~2.059,00 € | Mar 21 Gen 25 |
 | 3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide REF: 3D-FA102968CAS: 1334546-77-8 | Min. 95% | - - - | Prodotto fuori produzione |
3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide
CAS:1334546-77-8
Formula:
C12H13F6N3O3
Purezza:
98%
Peso molecolare:
361.2403
Ref: IN-DA01EGPW
| 5mg | 228,00 € | ||
| 25mg | 543,00 € | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 13 Gennaio 2025
Icenticaftor
CAS:1334546-77-8
Icenticaftor (QBW251) is an orally active potentiator of CFTR channel.
Formula:
C12H13F6N3O3
Purezza:
98.39%
Colore e forma:
Solid
Peso molecolare:
361.24
Ref: TM-T9499
| 1mg | 155,00 € | ||
| 5mg | 318,00 € | ||
| 10mg | 477,00 € | ||
| 25mg | 762,00 € | ||
| 50mg | 1.071,00 € | ||
| 100mg | 1.519,00 € | ||
| 200mg | 2.059,00 € | ||
| 1mL*10mM (DMSO) | 252,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
![3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridine…](https://static.cymitquimica.com/products/3D/thumb/FA102968.jpg)
3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide
CAS:1334546-77-8
The drug is a potentiator of the CFTR Cl- channel that is defective in cystic …
Formula:
C12H13F6N3O3
Purezza:
Min. 95%
Peso molecolare:
361.24 g/mol
- Ammine
- Eteri
- Amidi
- Amminoacidi (AA)
- Vedere altre categorie
- Alogenuri organici
- Eterocicli con azoto (N)
Ref: 3D-FA102968
| Dimensione non definita | Fuori produzione | Richiedi informazioni |
